Clinic offers both FDA cleared treatments for major depressive disorder (MDD) and obsessive-compulsive disorder (OCD)

Pittsburgh, PA. – April 5, 2021 – The Nexus Group, a leading integrative psychiatry clinic in Western Pennsylvania that focuses on the interface between physical and mental health, announced today it is offering BrainsWay's Deep Transcranial Magnetic Stimulation (Deep TMS) treatment for patients with major depressive disorder (MDD) and obsessive-compulsive disorder (OCD).

“The current pandemic has resulted in a significant uptick in mental health cases, underscoring the importance of providing individualized and noninvasive treatments, and we are honored to offer our patients this for both depression and OCD through Deep TMS,” said Dr. Gregory Thorkelson, M.D., board-certified psychiatrist and medical director of The Nexus Group. “I always feel humbled and honored to be a part of my patients’ journey to optimal well-being, and am excited to continue seeing this same success for future patients who walk through our doors.”

An expert on mental health disorders, Dr. Thorkelson has completed advanced training in Transcranial Magnetic Stimulation (TMS) at both Duke University and Harvard University medical schools, and serves as one of the premier psychiatry specialists in the Pittsburgh metropolitan area. He frequently collaborates with providers across the globe to aid in advancing the field of Deep TMS through research and practice of this technology. Additionally, Dr. Thorkelson holds a prestigious European TMS Certification, and was awarded a Visiting Fellowship in Electroconvulsive Therapy at The University of Pittsburgh.

BrainsWay’s Deep TMS device noninvasively administers magnetic waves through a cushioned helmet to target deep structures of the brain that impact depression and OCD symptoms. The treatment offers a medication-free solution, and patients can return to normal activities, such as driving, immediately following the 20-minute sessions. Because Deep TMS penetrates deeper and broader in the brain than traditional TMS, there is evidence that response rates are higher than traditional TMS. BrainsWay has been treating depression with Deep TMS since the treatment received FDA clearance in 2013, and OCD since 2018.

The Nexus Group offers comprehensive psychiatric services, including prescription, medication management, and psychotherapy. The clinic is known for its thorough, evidence-based, and compassionate approach toward the broad spectrum of mental health disorders, through readily accessible psychiatric care for eligible patients. Prospective patients can visit thenexusgrouppc.com or call (412) 214-0042 to learn more.

The Nexus Group

The Nexus Group, the leading innovative, integrative psychiatry clinic in Western Pennsylvania focusing on the interface between physical and mental health. All Nexus providers are board certified and have years of experience in caring for patients with mental health disorders, including treatment resistant depression (TRD) and obsessive-compulsive disorder (OCD). The clinic takes a whole-body perspective to treatment, combining conventional psychiatry and psychotherapy with mind-body techniques to get to the root-cause of behavioral health conditions.

‍

‍

About BrainsWay

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy.

‍

Current indications include major depressive disorder, obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Cresskill, NJ and Jerusalem, Israel, BrainsWay is committed to increasing global awareness and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.

‍

‍